These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21066293)
41. [Indications, advantages and disadvantages of blood and plasma transfusions in pediatric practice]. DI GIACOMO BE Pediatria (Napoli); 1962; 70():163-71. PubMed ID: 13885997 [No Abstract] [Full Text] [Related]
42. [Effects of an infusion pump with peristaltic mechanism of action on various blood components in vitro]. Wagner B; Wüst T; Beeser HP Beitr Infusionsther; 1992; 30():454-9. PubMed ID: 1284759 [TBL] [Abstract][Full Text] [Related]
43. [Granulocyte transfusion as a part of compensation for a biological defect]. Borberg H; Gaczkowski A Immun Infekt; 1984 Aug; 12(4):193-200. PubMed ID: 6480027 [TBL] [Abstract][Full Text] [Related]
44. Indications for HLA typing in granulocyte and platelet concentrate transfusions. McCredie KB Prog Clin Biol Res; 1981; 65():101-7. PubMed ID: 7330067 [No Abstract] [Full Text] [Related]
46. [First results of the treatment of acute leukosis by exsanguino-transfusions]. CROIZAT P; REVOL L Lyon Med; 1948 Jul; 180(29):477-85. PubMed ID: 18879380 [No Abstract] [Full Text] [Related]
47. [First results of the treatment of acute leukosis by exsanguino-transfusions]. CROIZAT P; REVOL L Lyon Med; 1948 Jul; 180(29):492-500. PubMed ID: 18879384 [No Abstract] [Full Text] [Related]
48. Fresh Frozen Plasma Use in a Neonatal Unit in South Africa. Raban MS; Harrison MC J Trop Pediatr; 2015 Aug; 61(4):266-71. PubMed ID: 25920397 [TBL] [Abstract][Full Text] [Related]
49. Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle. Smetana K; Kuzelova K; Zápotocký M; Starková J; Hrkal Z; Trka J Eur J Histochem; 2007; 51(4):269-74. PubMed ID: 18162456 [TBL] [Abstract][Full Text] [Related]
50. [Treatment of 14 leukemias by simple blood transfusions; favorable results on the course of three lymphoid leukemias with splenic form]. VALLERY-RADOT P; HAMBURGER J Sem Hop; 1948 Aug; 24(61):1979-83. PubMed ID: 18883654 [No Abstract] [Full Text] [Related]
51. [Clinical data on the efficiency of thrombocyte and granulocyte transfusion in acute leukemia]. Kamanabroo D; Büchner T; Urbanitz D; Balleisen L; van de Loo J Med Welt; 1982 Dec; 33(51-52):1861-3. PubMed ID: 7162407 [No Abstract] [Full Text] [Related]
52. [Granulocyte substitution in febrile leukemia patients with bone marrow aplasia. 1. Results of a prospective study]. Scali G; von Felten A; Fehr J; Sauter C; Gmür J Schweiz Med Wochenschr; 1978 Oct; 108(41):1583-5. PubMed ID: 694487 [TBL] [Abstract][Full Text] [Related]
53. [Supportive therapies for myeloid leukemia including blood transfusion and growth factors]. Yao H; Ashihara E; Maekawa T Nihon Rinsho; 2009 Oct; 67(10):1951-7. PubMed ID: 19860196 [TBL] [Abstract][Full Text] [Related]
54. [ON OXIDASE-NEGATIVE MYELOBLASTS IN LEUKEMIA WITH SPECIAL REFERENCE TO THEIR ELECTRON MICROSCOPE PICTURE]. ITO T Nihon Ketsueki Gakkai Zasshi; 1963 Feb; 26():139-42. PubMed ID: 14043461 [No Abstract] [Full Text] [Related]
56. [Quality of transfusion means and protocols of massive transfusions]. Zhiburt EB; Vergopulo AA; Kopchenko TG; Gubanova MN Vestn Khir Im I I Grek; 2009; 168(2):75-7. PubMed ID: 19514398 [TBL] [Abstract][Full Text] [Related]